Search Results 131-140 of 14322 for Testosterone Undecanoate

  1. Drugs and Supplements that Start with T - Mayo Clinic

    Testosterone (intramuscular route, subcutaneous route). Testone CIK. Also ... Testosterone (intramuscular route, subcutaneous route) · Testosterone (nasal ...

  2. Mayo Clinic Radio: Mental Illness / Exercise in Extreme Heat / Testosterone Therapy

    Landon Trost shares the latest research on testosterone therapy for older men. Listen to the program on Saturday, Aug. 6, at 9:05 a.m. CDT, and follow ...

  3. BAY 1895344 Plus Topoisomerase-1 (Top1) Inhibitors In Patients With Advanced Solid Tumors, Phase I Studies With Expansion Cohorts In Small Cell Lung Carcinoma (SCLC), Poorly Differentiated Neuroendocrine Carcinoma (PD-NEC) And Pancreatic Adenocarcinoma (PDA) - Mayo Clinic

    The purpose of this study is to test the safety and tolerability of a drug called BAY 1895344 in combination with irinotecan or topotecan at different doses.

  4. TN-401, A Recombinant Adeno-associated Virus Serotype 9 (AAV9) Containing Plakophilin-2 (PKP2) Transgene, In Adults With PKP2 Mutation-associated Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC) - Mayo Clinic

    ... test result for HCV, HIV-1/HIV-2 or laboratory evidence of HBV at Screening defined as: Positive test result for HCV antibodies or HCV RNA at Screening;. HBV ...

  5. A Study To Test Adding Pembrolizumab To Olaparib Alone As Therapy For Patients With Pancreatic Cancer That Has Spread With Inherited BRCA Mutations - Mayo Clinic

    The primary purpose of this study is to evaluate the progression free survival (PFS) of advanced pancreatic cancer patients with germline BRCA1 or BRCA2 ...

  6. Safety Study Of SEA-CD40 In Cancer Patients - Mayo Clinic

    The study will test increasing doses of SEA-CD40 given at least every 3 weeks to small groups of patients. The goal is to find the highest dose of SEA-CD40 ...

  7. A Study To Test Sacituzumab Govitecan Therapy In Patients With HER2-Negative Breast Cancer And Brain Metastases - Mayo Clinic

    The purpose of this study is to analyze the effect of sacituzumab govitecan in treating patients with HER2-negative breast cancer that has spread to the brain ( ...

  8. A Study To Test The Addition Of Nivolumab To Chemotherapy To Treat Soft Tissue Sarcoma - Mayo Clinic

    Nivolumab works through the body's immune system to help the immune system act against tumor cells. Chemotherapy drugs, such as paclitaxel, work in different ...

  9. Clinical trials - Gastroenterology and Hepatology

    The primary aim of this study is to evaluate the distribution of marker levels determined by this multi-marker, multi-compartment blood DNA test approach across ...

  10. A Study To Test The Combination Of Cabozantinib, Nivolumab, And Ipilimumab (CaboNivoIpi) For Advanced Differentiated Thyroid Cancer - Mayo Clinic

    Cabozantinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Immunotherapy with monoclonal antibodies, such as ...